5 Stocks Jim Cramer and Hedge Funds Have In Common
In this article, we will be taking a look at 5 stocks Jim Cramer and hedge funds have in common.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 4,511,785 | $312,711,818 | +17% | 1.34% |
| 2. | 2,782,200 | $192,834,282 | -9% | 0.04% | |
| 3. | AQR Capital Management Cliff Asness | 2,741,707 | $189,369,702 | +23% | 0.41% |
| 4. | OrbiMed Advisors Samuel Isaly | 2,340,000 | $162,185,400 | -10% | 3.18% |
| 5. | 2,251,700 | $156,065,327 | -10% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.50 | 9,174 | Director | 22,109 | 2020-06-15 | Filing | |
| $58.90 | 88 | Director | 7,189 | 2019-12-04 | Filing | |
| $44.72 | 11,000 | Director | 11,397 | 2019-07-31 | Filing | |
| $47.29 | 5,000 | Director | 27,000 | 2019-05-16 | Filing | |
| $52.40 | 9,540 | Director | 12,935 | 2018-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing | |
| $74.65 | 240,000 | Officer, Director | 236,104 | 2023-02-06 | Filing | |
| $74.69 | 11,183 | Officer | 23,043 | 2023-02-06 | Filing | |
| $80.45 | 16,250 | Officer | 34,226 | 2022-11-09 | Filing | |
| $78.88 | 45,910 | Officer | 57,079 | 2022-11-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 204,588,409 | $14,180,022,627 | 0.36% | |
| 2. | 175,584,734 | $12,169,777,909 | 0.35% | |
| 3. | 91,711,366 | $6,356,490,604 | 0.35% | |
| 4. | 61,417,173 | $4,256,355,278 | 1.09% | |
| 5. | 49,304,603 | $3,417,302,005 | 0.31% |
News See All
15 Best Healthcare Stocks To Buy Now
In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience.
14 Best Biotech Stocks To Buy According To Hedge Funds
Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, and biotechnology, are making rapid leaps forward.
14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy.
5 Stocks Warren Buffett Sold
Berkshire Hathaway dropped Bristol-Myers Squibb Company (NYSE:BMY) in the first quarter of 2022 after years of holding.
15 Biggest Immunotherapy Companies in the World
In this article, we will take a look at the 15 biggest immunotherapy companies in the world.
Hedge Fund and Insider Trading News: Oasis Management, Alden Global Capital, Knighthead Capital Management, Calculo Capital, Caesars Entertainment Inc (CZR), Bristol-Myers Squibb Company (BMY), and More
Please don’t feed or throw objects at the fund managers.
20 Largest R&D Companies in the World
In this article, we will be taking a look at the 20 largest R&D companies in the world.
15 Best Income Stocks to Buy According to Analysts
In this article, we discuss 15 best income stocks according to analysts.
27 Largest Biotech Companies in the US
In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US.
Billionaire Hedge Funds
